MENU
+Compare
GNMLF
Stock ticker: OTC
AS OF
Jul 1 closing price
Price
$1.12
Change
-$0.02 (-1.75%)
Capitalization
867.64M

GNMLF Genomma Lab International SAB DE CV Forecast, Technical & Fundamental Analysis

Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer... Show more

GNMLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GNMLF with price predictions
Jul 03, 2025

GNMLF's RSI Oscillator is staying in oversold zone for 2 days

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Aroon Indicator entered an Uptrend today. In of 92 cases where GNMLF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 01, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GNMLF as a result. In of 37 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for GNMLF moved below the 200-day moving average on June 13, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.277) is normal, around the industry mean (62.813). P/E Ratio (9.470) is within average values for comparable stocks, (89.433). GNMLF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.037) settles around the average of (0.124) among similar stocks. P/S Ratio (0.790) is also within normal values, averaging (19.290).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GNMLF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNMLF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
GNMLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Avenida Antonio Dovalí Jaime, Number 70
Phone
+52 50810000
Employees
2157
Web
https://www.genommalab.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSSVX29.370.32
+1.10%
Carillon Chartwell Small Cap R-6
FSCTX24.490.19
+0.78%
Fidelity Advisor Small Cap M
AXVNX18.410.10
+0.55%
Acclivity Small Cap Value N
HSWTX20.810.04
+0.19%
Hartford Schroders International Stk R5
HDVVX14.540.02
+0.14%
Hartford International Equity R6

GNMLF and Stocks

Correlation & Price change

A.I.dvisor tells us that GNMLF and AQST have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNMLF and AQST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNMLF
1D Price
Change %
GNMLF100%
N/A
AQST - GNMLF
21%
Poorly correlated
+1.09%
LVRLF - GNMLF
20%
Poorly correlated
-8.29%
VEXTF - GNMLF
20%
Poorly correlated
+6.79%